— Know what they know.
Not Investment Advice

BMI NYSE

Badger Meter, Inc.
1W: +17.6% 1M: +19.9% 3M: +13.9% YTD: -13.2% 1Y: -18.1% 3Y: +13.6% 5Y: +54.2%
$151.75
-4.20 (-2.69%)
 
Weekly Expected Move ±7.8%
$127 $139 $151 $163 $175
NYSE · Industrials · Industrial - Machinery · Tech Score Buy · Power 74 · $4.4B mcap · 29M float · 1.55% daily turnover · Short 60% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z 11.87.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
63.2 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 21.3%  ·  5Y Avg: 20.9%
Cost Advantage
76
Intangibles
60
Switching Cost
60
Network Effect
40
Scale ★
80
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. BMI has a Narrow competitive edge (63.2/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 21.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$168
Low
$175
Avg Target
$187
High
Based on 5 analysts since Oct 22, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 5Hold: 10Sell: 3Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$155.11
Analysts9
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-27 Argus Research John Eade $240 $170 -70 +9.0% $155.95
2026-10-23 Seaport Global — $160 $175 +15 +15.4% $151.64
2026-10-23 RBC Capital — $162 $187 +25 +26.3% $148.04
2026-10-23 Stifel Nicolaus Nathan Jones $150 $168 +18 +12.3% $149.64
2026-10-23 Robert W. Baird — $167 $175 +8 +16.9% $149.64
2026-10-19 Stifel Nicolaus — $165 $150 -15 +18.6% $126.48
2026-10-13 Barclays William Grippin $112 $111 -1 -16.2% $132.39
2026-09-18 Northcoast Research — Initiated $148 — +16.0% $127.62
2026-07-28 Barclays William Grippin $109 $112 +3 -12.5% $127.99
2026-07-23 Seaport Global — $220 $160 -60 +28.2% $124.78
2026-07-23 RBC Capital — $169 $162 -7 +30.2% $124.45
2026-07-23 Robert W. Baird — $145 $167 +22 +36.7% $122.13
2026-07-23 Stifel Nicolaus — $170 $165 -5 +30.3% $126.67
2026-07-20 Stifel Nicolaus — $140 $170 +30 +13.7% $149.48
2026-07-13 Barclays — $110 $109 -1 -24.4% $144.18
2026-05-22 Stifel Nicolaus Nathan Jones $174 $140 -34 +16.4% $120.24
2026-04-20 RBC Capital — $191 $169 -22 +49.4% $113.09
2026-04-20 Robert W. Baird — $165 $145 -20 +25.5% $115.54
2026-04-20 Barclays — $136 $110 -26 -4.8% $115.54
2026-04-14 Stifel Nicolaus — $166 $174 +8 +8.1% $161.00
2026-01-29 Seaport Global Scott Graham $255 $220 -35 +55.5% $141.52
2026-01-29 Deutsche Bank Andrew Krill $184 $167 -17 +15.9% $144.07
2026-01-29 RBC Capital Jeffrey Reive $229 $191 -38 +30.9% $145.93
2026-01-29 Robert W. Baird Robert Mason $205 $165 -40 +12.8% $146.32
2026-01-29 Stifel Nicolaus Nathan Jones $215 $166 -49 +12.8% $147.15
2026-01-29 Barclays — $157 $136 -21 -7.1% $146.32
2026-01-07 Barclays William Grippin Initiated $157 — -13.7% $181.83
2025-12-12 Jefferies — Initiated $220 — +20.7% $182.34
2025-10-22 RBC Capital Jeffrey Reive Initiated $229 — +29.1% $177.35
2025-10-21 Stifel Nicolaus Nathan Jones $208 $215 +7 +21.2% $177.35
2025-10-20 Stifel Nicolaus Nathan Jones $224 $208 -16 +15.6% $179.94
2025-10-20 Robert W. Baird — $184 $205 +21 +13.9% $179.94
2025-08-25 Seaport Global — $250 $255 +5 +37.8% $185.07
2025-07-23 Stifel Nicolaus Nathan Jones $233 $224 -9 +13.2% $197.83
2025-07-21 Stifel Nicolaus Nathan Jones $196 $233 +37 -5.3% $246.09
2025-04-24 Argus Research Kristina Ruggeri $230 $240 +10 +10.7% $216.73
2025-04-16 Stifel Nicolaus Nathan Jones $209 $196 -13 +6.6% $183.90
2025-02-03 Stifel Nicolaus Nathan Jones $175 $209 +34 -3.1% $215.70
2024-10-21 Argus Research Kristina Ruggeri $218 $230 +12 +12.3% $204.82
2024-10-18 Seaport Global Scott Graham $235 $250 +15 +18.2% $211.47
2024-09-11 Seaport Global Scott Graham Initiated $235 — +20.4% $195.19
2024-07-23 Argus Research Kristina Ruggeri Initiated $218 — +8.2% $201.52
2024-07-22 Robert W. Baird Richard Eastman $180 $184 +4 -3.4% $190.56
2024-04-19 Robert W. Baird Richard Eastman Initiated $180 — +0.9% $178.48
2024-04-19 Deutsche Bank Andy Krill Initiated $184 — +3.1% $178.48
2024-04-18 Stifel Nicolaus Nathan Jones Initiated $175 — -1.9% $178.48

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 27, 2026
DCF
4
ROE
5
ROA
5
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. BMI receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-08-20 B B+
2026-08-18 B+ B
2026-05-12 A- B+
2026-05-11 B+ A-
2026-04-21 B B+
2026-04-17 B+ B
2026-03-02 B B+
2026-01-03 B+ B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 60 Grade A+
Profitability
65
Balance Sheet
82
Earnings Quality
81
Growth
32
Value
54
Momentum
63
Safety
100
Cash Flow
64
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. BMI scores highest in Safety (100/100) and lowest in Growth (32/100). An overall grade of A+ places BMI among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
10.16
Safe Zone
Piotroski F-Score
5/9
✓ ✓ ✗ ✓ ✗ ✗ ✓ ✓ ✗
Beneish M-Score
-2.59
Unlikely Manipulator
Ohlson O-Score
-9.45
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA
Score: 87.9/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.25x
Accruals: -3.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. BMI scores 10.16, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. BMI scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. BMI's score of -2.59 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. BMI's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. BMI receives an estimated rating of AA (score: 87.9/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). BMI's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
34.89x
PEG
-4.34x
P/S
4.99x
P/B
6.70x
P/FCF
25.07x
P/OCF
22.49x
EV/EBITDA
17.49x
EV/Revenue
3.97x
EV/EBIT
20.78x
EV/FCF
24.59x
Earnings Yield
3.55%
FCF Yield
3.99%
Shareholder Yield
5.09%
Graham Number
$47.16
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 34.9x earnings, BMI commands a growth premium. Graham's intrinsic value formula yields $47.16 per share, 222% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.750
NI / EBT
×
Interest Burden
1.002
EBT / EBIT
×
EBIT Margin
0.191
EBIT / Rev
×
Asset Turnover
0.917
Rev / Assets
×
Equity Multiplier
1.420
Assets / Equity
=
ROE
18.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. BMI's ROE of 18.7% is driven by Asset Turnover (0.917), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
14.78%
Fair P/E
38.07x
Intrinsic Value
$166.83
Price/Value
0.74x
Margin of Safety
25.95%
Premium
-25.95%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with BMI's realized 14.8% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. BMI trades at a -26% premium to its adjusted intrinsic value of $166.83, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.1x compares to the current market P/E of 34.9x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$151.68
Median 1Y
$165.52
5th Pctile
$87.31
95th Pctile
$316.02
Ann. Volatility
37.7%
Analyst Target
$155.11
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Kenneth C. Bockhorst
Chairman, President & CEO
$880,000 $3,042,144 $5,932,862
Robert A. Wrocklage
Senior Vice President - Chief Financial Officer
$500,000 $709,586 $1,952,394
Sheryl L. Hopkins
Vice President - Human Resources
$360,000 $228,187 $984,668
Kimberly K. Stoll
Vice President - Sales and Marketing
$325,000 $228,187 $890,043
William R. A.
Bergum Vice President - General Counsel
$300,000 $228,187 $867,776

CEO Pay Ratio

Insufficient data for pay ratio.

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,477
+12.1% YoY
Revenue / Employee
$370,070
Rev: $916,663,000
Profit / Employee
$57,180
NI: $141,634,000
SGA / Employee
—
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE 15.9% 15.8% 16.1% 16.3% 15.7% 16.5% 17.4% 18.7% 19.3% 20.6% 21.7% 21.9% 22.3% 22.8% 21.9% 21.5% 21.5% 19.6% 18.5% 18.7% 18.70%
ROA 12.2% 11.9% 12.1% 12.1% 11.7% 12.1% 12.7% 13.5% 14.0% 14.9% 15.7% 15.9% 16.3% 16.3% 15.8% 15.6% 15.8% 14.0% 13.0% 13.2% 13.17%
ROIC 19.3% 19.2% 20.3% 21.5% 21.7% 21.5% 22.8% 25.2% 27.6% 29.3% 32.2% 34.2% 38.1% 25.1% 25.4% 26.7% 28.3% 26.1% 20.8% 21.3% 21.27%
ROCE 17.5% 17.4% 18.0% 18.5% 17.7% 18.1% 18.7% 19.3% 20.2% 21.3% 22.0% 22.4% 22.6% 22.5% 21.9% 22.0% 22.8% 21.7% 20.3% 21.2% 21.17%
Gross Margin 40.4% 38.3% 39.7% 38.9% 38.7% 39.5% 39.5% 39.1% 39.2% 39.3% 39.4% 40.2% 40.3% 42.9% 41.1% 40.7% 42.1% 41.7% 40.8% 41.9% 41.90%
Operating Margin 16.8% 14.2% 16.0% 16.1% 15.3% 15.7% 16.8% 16.9% 17.6% 18.6% 19.2% 19.5% 19.1% 22.2% 18.8% 19.6% 19.5% 17.4% 17.7% 20.2% 20.23%
Net Margin 12.7% 10.8% 12.1% 12.1% 11.9% 12.2% 12.8% 13.9% 13.6% 14.8% 15.3% 15.4% 15.0% 17.3% 14.5% 14.9% 15.2% 13.5% 13.4% 15.2% 15.22%
EBITDA Margin 21.9% 19.3% 20.8% 20.6% 19.4% 20.1% 20.7% 20.7% 21.5% 22.7% 22.9% 23.3% 19.1% 26.0% 22.9% 23.8% 24.2% 19.4% 22.2% 24.6% 24.65%
FCF Margin 16.0% 11.6% 12.4% 13.4% 13.5% 13.9% 13.4% 13.6% 13.9% 13.9% 15.0% 16.3% 17.2% 18.0% 18.3% 18.5% 18.5% 18.9% 17.0% 16.1% 16.15%
OCF Margin 17.3% 12.7% 13.3% 14.0% 14.6% 15.4% 15.0% 15.2% 15.7% 15.3% 16.3% 17.5% 18.8% 19.5% 20.0% 20.1% 20.0% 20.6% 18.9% 18.0% 18.00%
ROE 3Y Avg snapshot only 19.77%
ROE 5Y Avg snapshot only 18.46%
ROA 3Y Avg snapshot only 14.14%
ROIC 3Y Avg snapshot only 18.24%
ROIC Economic snapshot only 19.58%
Cash ROA snapshot only 16.80%
Cash ROIC snapshot only 27.19%
CROIC snapshot only 24.40%
NOPAT Margin snapshot only 14.08%
Pretax Margin snapshot only 19.14%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 5.80%
SBC / Revenue snapshot only 0.89%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio 49.44 45.92 35.75 39.69 46.79 48.71 54.69 48.43 48.01 45.67 47.79 53.28 49.04 41.29 52.65 37.64 36.05 34.04 34.29 28.19 34.885
P/S Ratio 5.96 5.43 4.29 4.74 5.50 5.88 6.71 6.19 6.32 6.31 6.90 7.88 7.41 6.50 8.18 5.80 5.57 4.96 4.89 4.05 4.992
P/B Ratio 7.47 6.89 5.51 6.22 7.03 7.61 8.90 8.40 8.61 8.72 9.58 10.72 10.11 8.64 10.55 7.43 7.16 6.44 6.31 5.48 6.700
P/FCF 37.27 46.97 34.64 35.43 40.66 42.44 50.27 45.59 45.32 45.27 46.04 48.48 43.08 36.10 44.65 31.41 30.09 26.29 28.70 25.07 25.067
P/OCF 34.40 42.63 32.15 33.94 37.76 38.24 44.91 40.60 40.38 41.13 42.39 44.97 39.52 33.26 40.89 28.86 27.80 24.08 25.87 22.49 22.492
EV/EBITDA 27.46 25.44 19.85 21.93 26.22 28.03 32.10 29.37 29.13 28.19 30.07 33.39 32.04 27.72 34.88 24.18 21.99 20.85 21.29 17.49 17.493
EV/Revenue 5.79 5.26 4.10 4.54 5.26 5.67 6.49 5.94 6.05 6.04 6.61 7.56 7.06 6.35 7.99 5.57 5.32 4.73 4.78 3.97 3.970
EV/EBIT 37.19 34.28 26.39 28.68 34.07 35.92 40.55 36.69 36.08 34.55 36.52 40.33 36.93 31.68 39.88 27.61 26.06 24.33 25.11 20.78 20.784
EV/FCF 36.19 45.49 33.13 33.88 38.86 40.88 48.59 43.80 43.36 43.34 44.11 46.50 41.01 35.24 43.62 30.19 28.76 25.07 28.06 24.59 24.590
Earnings Yield 2.0% 2.2% 2.8% 2.5% 2.1% 2.1% 1.8% 2.1% 2.1% 2.2% 2.1% 1.9% 2.0% 2.4% 1.9% 2.7% 2.8% 2.9% 2.9% 3.5% 3.55%
FCF Yield 2.7% 2.1% 2.9% 2.8% 2.5% 2.4% 2.0% 2.2% 2.2% 2.2% 2.2% 2.1% 2.3% 2.8% 2.2% 3.2% 3.3% 3.8% 3.5% 4.0% 3.99%
Price/Tangible Book snapshot only 18.692
EV/OCF snapshot only 22.063
EV/Gross Profit snapshot only 9.535
Acquirers Multiple snapshot only 21.161
Shareholder Yield snapshot only 5.09%
Graham Number snapshot only $47.16
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 3.18 3.18 3.12 3.20 3.15 3.12 3.27 3.28 3.35 3.48 3.69 4.10 4.57 2.92 3.23 3.22 3.36 3.00 2.42 2.48 2.481
Quick Ratio 1.97 2.01 1.98 2.08 2.07 1.97 2.05 2.14 2.19 2.30 2.52 2.87 3.36 1.86 2.17 2.23 2.36 1.97 1.39 1.36 1.359
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Net Debt/Equity -0.22 -0.22 -0.24 -0.27 -0.31 -0.28 -0.30 -0.33 -0.37 -0.37 -0.40 -0.44 -0.49 -0.20 -0.24 -0.29 -0.32 -0.30 -0.14 -0.10 -0.104
Debt/Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Debt/EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Net Debt/EBITDA -0.82 -0.83 -0.91 -1.00 -1.22 -1.07 -1.11 -1.20 -1.31 -1.26 -1.32 -1.42 -1.62 -0.67 -0.83 -0.97 -1.02 -1.01 -0.48 -0.34 -0.340
Interest Coverage 3930.15 5694.07 6927.17 3371.65 3966.95 10384.11 — — — — — — — — — — — — — — —
Equity Multiplier 1.32 1.33 1.35 1.36 1.36 1.38 1.39 1.40 1.39 1.39 1.39 1.36 1.35 1.40 1.38 1.39 1.36 1.41 1.46 1.45 1.449
Cash Ratio snapshot only 0.458
Defensive Interval snapshot only 325.5 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 1.01 1.01 1.01 1.01 1.00 1.00 1.03 1.06 1.07 1.08 1.09 1.08 1.08 1.04 1.02 1.01 1.02 0.96 0.91 0.92 0.917
Inventory Turnover 3.31 3.34 3.20 3.27 3.15 3.06 2.99 3.11 3.12 3.07 3.10 3.17 3.35 3.26 3.33 3.40 3.62 3.24 3.18 3.22 3.224
Receivables Turnover 7.92 7.44 7.57 7.05 7.94 7.29 7.82 7.75 8.79 8.39 8.22 8.81 9.85 8.35 7.81 8.64 9.32 8.07 7.38 7.77 7.768
Payables Turnover 7.81 6.77 6.29 6.23 6.10 5.46 5.38 5.40 5.57 5.29 5.36 5.99 7.24 6.14 6.04 7.19 8.36 5.83 6.01 7.34 7.344
DSO 46 49 48 52 46 50 47 47 42 43 44 41 37 44 47 42 39 45 49 47 47.0 days
DIO 110 109 114 112 116 119 122 117 117 119 118 115 109 112 110 107 101 113 115 113 113.2 days
DPO 47 54 58 59 60 67 68 68 65 69 68 61 50 59 60 51 44 63 61 50 49.7 days
Cash Conversion Cycle 110 104 104 105 102 102 101 97 93 93 94 95 96 96 96 99 96 95 104 111 110.5 days
Fixed Asset Turnover snapshot only 10.557
Operating Cycle snapshot only 160.2 days
Cash Velocity snapshot only 12.973
Capital Intensity snapshot only 1.071
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 18.7% 19.5% 14.6% 15.0% 11.9% 14.0% 17.9% 20.7% 24.4% 25.1% 24.0% 20.2% 17.5% 15.1% 11.8% 12.1% 10.9% 5.2% 0.8% -2.2% -2.21%
Net Income 23.4% 19.9% 15.2% 16.8% 9.2% 16.4% 20.6% 29.0% 39.3% 43.0% 45.9% 39.3% 34.9% 31.2% 20.3% 16.7% 13.4% -2.7% -7.4% -8.8% -8.82%
EPS 22.9% 19.7% 15.0% 16.7% 9.1% 16.2% 20.2% 28.5% 38.9% 42.6% 45.5% 38.9% 35.4% 30.9% 20.1% 16.5% 12.7% -2.0% -6.0% -6.6% -6.57%
FCF 0.3% -25.6% -8.7% 10.3% -5.3% 36.7% 27.1% 22.3% 28.2% 25.7% 39.2% 44.1% 44.9% 48.7% 36.6% 27.2% 19.3% 10.2% -6.2% -14.4% -14.44%
EBITDA 18.0% 15.9% 11.1% 14.7% 6.5% 11.5% 15.3% 18.1% 28.8% 32.5% 34.9% 34.5% 24.6% 23.0% 16.5% 14.1% 21.9% 4.2% -1.1% -3.7% -3.68%
Op. Income 20.8% 19.4% 14.2% 20.4% 10.9% 17.1% 21.2% 23.7% 35.2% 38.6% 40.3% 39.1% 33.8% 31.8% 23.0% 19.1% 16.1% -0.9% -6.0% -7.9% -7.94%
OCF Growth snapshot only -12.37%
Asset Growth snapshot only -3.54%
Equity Growth snapshot only -7.31%
Shares Change snapshot only -2.41%
Dividend Growth snapshot only 16.93%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y 5.2% 6.2% 8.1% 9.5% 10.0% 11.4% 14.9% 16.7% 18.2% 19.4% 18.8% 18.6% 17.8% 17.9% 17.8% 17.6% 17.5% 14.8% 11.8% 9.6% 9.65%
Revenue 5Y 5.1% 5.7% 6.2% 6.8% 7.0% 7.9% 8.7% 9.4% 10.2% 11.3% 13.0% 13.8% 14.2% 14.8% 16.0% 16.5% 16.6% 15.6% 13.6% 12.8% 12.84%
EPS 3Y 29.6% 25.4% 20.8% 12.6% 11.9% 13.8% 18.4% 20.4% 23.0% 25.6% 26.2% 27.7% 27.1% 29.4% 28.0% 27.7% 28.5% 22.3% 18.0% 14.8% 14.78%
EPS 5Y 13.3% 13.0% 13.2% 14.4% 13.8% 16.3% 21.5% 28.9% 27.0% 26.7% 25.2% 20.6% 21.4% 22.4% 23.7% 23.1% 23.2% 20.5% 17.8% 17.8% 17.79%
Net Income 3Y 29.9% 25.5% 20.9% 12.8% 12.1% 14.1% 18.6% 20.7% 23.3% 25.9% 26.5% 28.0% 27.1% 29.7% 28.4% 28.0% 28.7% 22.2% 17.6% 14.0% 14.00%
Net Income 5Y 13.5% 13.2% 13.4% 14.6% 14.0% 16.5% 21.8% 29.1% 27.2% 26.9% 25.5% 20.9% 21.5% 22.7% 24.0% 23.4% 23.5% 20.6% 17.7% 17.4% 17.41%
EBITDA 3Y 20.2% 18.1% 15.2% 10.8% 9.7% 11.0% 14.3% 14.8% 17.4% 19.6% 20.0% 22.1% 19.6% 22.0% 21.9% 21.9% 25.1% 19.3% 15.8% 13.9% 13.91%
EBITDA 5Y 7.8% 7.7% 7.7% 8.8% 7.2% 9.1% 13.1% 17.6% 18.9% 19.5% 18.9% 16.6% 16.2% 17.4% 18.6% 18.4% 19.7% 17.0% 14.8% 14.9% 14.88%
Gross Profit 3Y 8.2% 7.6% 8.7% 10.3% 10.4% 11.7% 15.1% 16.6% 18.0% 18.6% 17.6% 17.8% 17.0% 18.9% 19.4% 19.5% 20.2% 16.9% 13.8% 11.9% 11.89%
Gross Profit 5Y 6.4% 6.6% 6.8% 7.7% 7.1% 8.6% 9.8% 10.2% 11.2% 11.9% 13.2% 14.4% 15.0% 15.9% 17.3% 17.6% 17.8% 16.3% 14.1% 13.5% 13.51%
Op. Income 3Y 11.4% 9.3% 11.6% 13.1% 12.0% 13.6% 18.0% 18.9% 21.9% 24.7% 24.8% 27.5% 26.1% 28.8% 27.9% 27.0% 28.1% 21.9% 17.5% 15.1% 15.10%
Op. Income 5Y 9.2% 9.2% 9.4% 11.2% 9.4% 12.4% 14.2% 14.5% 15.7% 16.2% 18.8% 20.0% 20.5% 21.8% 23.2% 22.7% 23.0% 20.4% 17.6% 17.8% 17.82%
FCF 3Y 16.0% -1.9% -1.0% -0.2% 1.5% -1.6% -0.5% 2.0% 6.8% 8.5% 17.4% 24.8% 20.8% 36.7% 34.2% 30.9% 30.4% 27.2% 21.3% 16.2% 16.18%
FCF 5Y 12.1% 8.9% 4.2% 9.3% 17.1% 22.5% 28.5% 22.4% 13.7% 10.2% 11.4% 11.9% 14.2% 12.2% 13.4% 14.2% 16.1% 15.9% 15.7% 16.2% 16.16%
OCF 3Y 13.2% -2.5% -2.1% -1.7% 0.7% -0.8% 0.8% 3.0% 7.1% 8.2% 15.6% 21.5% 21.0% 36.0% 34.8% 32.7% 30.6% 26.5% 20.9% 15.9% 15.89%
OCF 5Y 9.3% 5.6% 1.6% 4.6% 10.6% 15.6% 20.2% 18.4% 12.8% 9.7% 10.8% 11.5% 13.9% 12.3% 13.7% 14.2% 15.4% 15.6% 15.1% 15.1% 15.05%
Assets 3Y 10.6% 10.6% 11.4% 11.2% 12.6% 13.7% 14.5% 15.4% 15.0% 15.2% 16.1% 15.7% 15.4% 18.1% 18.7% 19.4% 17.3% 15.3% 14.8% 11.0% 11.01%
Assets 5Y 8.7% 9.1% 8.1% 8.3% 9.0% 9.9% 10.4% 11.4% 12.8% 13.0% 14.1% 14.0% 14.1% 15.9% 16.3% 16.9% 15.6% 14.8% 14.9% 12.7% 12.70%
Equity 3Y 9.9% 9.9% 9.6% 9.3% 10.1% 10.9% 11.7% 11.9% 12.7% 13.1% 13.8% 14.7% 14.6% 16.1% 17.6% 18.4% 17.3% 14.7% 12.8% 9.7% 9.74%
Book Value 3Y 9.7% 9.8% 9.4% 9.1% 9.9% 10.7% 11.5% 11.6% 12.4% 12.9% 13.5% 14.4% 14.6% 15.9% 17.3% 18.2% 17.1% 14.7% 13.2% 10.5% 10.50%
Dividend 3Y 2.7% 3.2% 3.6% 3.6% 3.7% 3.8% 3.9% 4.4% 5.0% 5.6% 6.1% 6.6% 7.3% 7.4% 7.8% 7.1% 6.5% 6.1% 5.8% 5.2% 5.22%
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 0.66 0.70 0.77 0.77 0.79 0.79 0.80 0.78 0.77 0.80 0.87 0.90 0.92 0.94 0.97 0.98 0.98 0.98 0.96 0.94 0.936
Earnings Stability 0.77 0.84 0.88 0.85 0.89 0.94 0.99 0.94 0.93 0.92 0.91 0.87 0.87 0.89 0.93 0.95 0.95 0.93 0.90 0.89 0.890
Margin Stability 0.97 0.98 0.98 0.97 0.98 0.98 0.97 0.98 0.97 0.98 0.99 0.98 0.98 0.98 0.98 0.98 0.97 0.98 0.97 0.97 0.974
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.000
Earn. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.91 0.92 0.94 0.93 0.96 0.93 0.92 0.88 0.84 0.83 0.82 0.84 0.86 0.88 0.92 0.93 0.95 0.99 0.97 0.96 0.965
Earnings Smoothness 0.79 0.82 0.86 0.84 0.91 0.85 0.81 0.75 0.67 0.65 0.63 0.67 0.70 0.73 0.82 0.85 0.87 0.97 0.92 0.91 0.908
ROE Trend 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.02 0.03 0.04 0.04 0.04 0.04 0.04 0.02 0.01 0.01 -0.01 -0.02 -0.01 -0.005
Gross Margin Trend 0.02 0.00 -0.00 -0.01 -0.01 -0.01 -0.01 -0.01 -0.00 -0.00 -0.00 0.00 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.012
FCF Margin Trend -0.02 -0.08 -0.06 -0.04 -0.04 -0.01 -0.01 -0.00 -0.01 0.01 0.02 0.03 0.03 0.04 0.04 0.04 0.03 0.03 0.00 -0.01 -0.012
Sustainable Growth Rate 10.1% 9.9% 10.2% 10.3% 9.8% 10.6% 11.4% 12.6% 13.3% 14.5% 15.6% 15.7% 15.9% 16.4% 15.4% 15.0% 14.9% 12.8% 11.6% 11.7% 11.65%
Internal Growth Rate 8.4% 8.1% 8.3% 8.3% 7.9% 8.4% 9.1% 10.0% 10.7% 11.7% 12.7% 12.9% 13.1% 13.3% 12.5% 12.2% 12.3% 10.0% 8.9% 8.9% 8.94%
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income 1.44 1.08 1.11 1.17 1.24 1.27 1.22 1.19 1.19 1.11 1.13 1.18 1.24 1.24 1.29 1.30 1.30 1.41 1.33 1.25 1.253
FCF/OCF 0.92 0.91 0.93 0.96 0.93 0.90 0.89 0.89 0.89 0.91 0.92 0.93 0.92 0.92 0.92 0.92 0.92 0.92 0.90 0.90 0.897
FCF/Net Income snapshot only 1.125
OCF/EBITDA snapshot only 0.793
CapEx/Revenue 1.3% 1.2% 1.0% 0.6% 1.0% 1.5% 1.6% 1.7% 1.7% 1.4% 1.3% 1.3% 1.6% 1.5% 1.7% 1.6% 1.5% 1.7% 1.9% 1.8% 1.85%
CapEx/Depreciation snapshot only 0.514
Accruals Ratio -0.05 -0.01 -0.01 -0.02 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.03 -0.04 -0.04 -0.05 -0.05 -0.05 -0.06 -0.04 -0.03 -0.033
Sloan Accruals snapshot only -0.159
Cash Flow Adequacy snapshot only 2.479
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield 0.7% 0.8% 1.0% 0.9% 0.8% 0.7% 0.6% 0.7% 0.7% 0.6% 0.6% 0.5% 0.6% 0.7% 0.6% 0.8% 0.9% 1.0% 1.1% 1.3% 1.08%
Dividend/Share $0.75 $0.78 $0.80 $0.82 $0.85 $0.87 $0.90 $0.94 $0.99 $1.03 $1.07 $1.14 $1.22 $1.28 $1.35 $1.41 $1.47 $1.54 $1.61 $1.65 $1.64
Payout Ratio 36.4% 37.1% 36.5% 36.4% 37.4% 35.8% 34.1% 32.5% 31.4% 29.7% 28.1% 28.4% 28.7% 28.3% 29.5% 30.1% 30.7% 34.6% 37.2% 37.7% 37.68%
FCF Payout Ratio 27.4% 37.9% 35.3% 32.5% 32.5% 31.2% 31.3% 30.6% 29.6% 29.4% 27.1% 25.8% 25.2% 24.7% 25.0% 25.1% 25.7% 26.7% 31.2% 33.5% 33.51%
Total Payout Ratio 37.1% 37.8% 37.1% 37.1% 38.1% 36.4% 34.1% 32.5% 31.4% 29.7% 28.1% 28.4% 28.7% 28.3% 29.5% 30.1% 41.3% 75.4% 99.7% 1.4% 1.44%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.10 0.11 0.13 0.13 0.13 0.13 0.13 0.16 0.17 0.19 0.21 0.22 0.24 0.26 0.27 0.24 0.22 0.20 0.18 0.15 0.155
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 1.2% 1.8% 3.8% 3.76%
Net Buyback Yield -0.0% -0.0% -0.1% 0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% 0.0% 0.3% 1.2% 1.8% 3.8% 3.75%
Total Shareholder Return 0.7% 0.8% 1.0% 0.9% 0.8% 0.7% 0.6% 0.6% 0.6% 0.6% 0.6% 0.5% 0.6% 0.7% 0.6% 0.8% 1.1% 2.2% 2.9% 5.1% 5.09%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 0.77 0.77 0.77 0.76 0.76 0.76 0.75 0.77 0.76 0.76 0.77 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.750
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.01 1.01 1.02 1.03 1.03 1.04 1.04 1.05 1.05 1.05 1.04 1.02 1.01 1.00 1.00 1.00 1.002
EBIT Margin 0.16 0.15 0.16 0.16 0.15 0.16 0.16 0.16 0.17 0.17 0.18 0.19 0.19 0.20 0.20 0.20 0.20 0.19 0.19 0.19 0.191
Asset Turnover 1.01 1.01 1.01 1.01 1.00 1.00 1.03 1.06 1.07 1.08 1.09 1.08 1.08 1.04 1.02 1.01 1.02 0.96 0.91 0.92 0.917
Equity Multiplier 1.31 1.32 1.33 1.34 1.34 1.36 1.37 1.38 1.38 1.39 1.39 1.38 1.37 1.40 1.38 1.38 1.36 1.40 1.42 1.42 1.420
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $2.07 $2.09 $2.19 $2.25 $2.26 $2.43 $2.63 $2.90 $3.14 $3.47 $3.82 $4.03 $4.25 $4.54 $4.59 $4.69 $4.79 $4.45 $4.31 $4.38 $4.38
Book Value/Share $13.72 $13.96 $14.18 $14.40 $15.05 $15.57 $16.15 $16.72 $17.52 $18.16 $19.07 $20.01 $20.64 $21.70 $22.91 $23.75 $24.14 $23.51 $23.44 $22.55 $22.65
Tangible Book/Share $7.80 $8.36 $8.77 $9.17 $9.78 $9.68 $10.33 $11.04 $11.74 $12.53 $13.53 $14.46 $15.17 $9.44 $10.68 $11.62 $12.16 $11.63 $7.48 $6.61 $6.61
Revenue/Share $17.20 $17.70 $18.22 $18.86 $19.23 $20.13 $21.40 $22.68 $23.87 $25.12 $26.47 $27.20 $28.14 $28.83 $29.55 $30.46 $31.03 $30.54 $30.23 $30.52 $30.65
FCF/Share $2.75 $2.05 $2.26 $2.53 $2.60 $2.79 $2.86 $3.08 $3.33 $3.50 $3.97 $4.42 $4.84 $5.19 $5.41 $5.62 $5.74 $5.76 $5.15 $4.93 $4.95
OCF/Share $2.98 $2.25 $2.43 $2.64 $2.80 $3.10 $3.20 $3.46 $3.74 $3.85 $4.31 $4.77 $5.28 $5.64 $5.91 $6.12 $6.22 $6.29 $5.72 $5.49 $5.52
Cash/Share $2.97 $3.04 $3.41 $3.91 $4.69 $4.36 $4.82 $5.53 $6.51 $6.76 $7.66 $8.76 $10.06 $4.44 $5.59 $6.82 $7.65 $7.00 $3.29 $2.35 $2.36
EBITDA/Share $3.63 $3.66 $3.77 $3.90 $3.86 $4.07 $4.33 $4.59 $4.95 $5.38 $5.82 $6.16 $6.20 $6.60 $6.77 $7.02 $7.51 $6.92 $6.79 $6.93 $6.93
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Net Debt/Share $-2.97 $-3.04 $-3.41 $-3.91 $-4.69 $-4.36 $-4.82 $-5.53 $-6.51 $-6.76 $-7.66 $-8.76 $-10.06 $-4.44 $-5.59 $-6.82 $-7.65 $-7.00 $-3.29 $-2.35 $-2.35
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 10.161
Altman Z-Prime snapshot only 17.957
Piotroski F-Score 6 6 6 6 5 6 6 7 7 6 6 7 8 6 6 6 6 6 4 5 5
Beneish M-Score -2.60 -2.25 -2.37 -2.47 -2.46 -2.55 -2.46 -2.48 -2.46 -2.43 -2.32 -2.56 -2.65 -2.17 -2.25 -2.17 -1.95 -2.59 -2.38 -2.59 -2.592
Ohlson O-Score snapshot only -9.450
ROIC (Greenblatt) snapshot only 55.54%
Net-Net WC snapshot only $2.61
EVA snapshot only $65720366.31
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only AA
Credit Score 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 89.00 88.50 87.93 87.926
Credit Grade snapshot only 3
Credit Trend snapshot only -1.074
Implied Spread (bps) snapshot only 80.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 80

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms